Florian Grebien did his PhD jointly supervised by Ernst Müllner of the Medical University Vienna and Hartmut Beug of the Research Institute for Molecular Pathology (IMP) in Vienna. For his post-doctoral research he joined the team of Giulio Superti-Furga at the Research Center for Molecular Medicine (CeMM), Vienna. From 2014 to 2018, he was a Principal Investigator and group leader at the Ludwig Boltzmann Institute for Cancer Research (LBI-CR) in Vienna. In January 2018, he was appointed Professor and head of the institute for Medical Biochemistry at the University of Veterinary Medicine Vienna.
Florian Grebien’s research focuses on acute myeloid leukemia (AML), a cancer of white blood cells that is characterized by the rapid growth of abnormal myeloid cells that accumulate in the bone marrow and interfere with the production of normal blood cells. The Grebien laboratory aims to contribute to a better understanding of the molecular mechanisms of leukemia development. We study cellular and molecular effects of leukemia-associated oncoproteins through the development and use of novel tools, including cell culture and mouse models, Next Generation Sequencing, Mass Spectrometry and primary patient samples.

Manuela Thullner
Secretary


Thomas Eder
PostDoc
“As bioinformatician I have a special interest in cutting edge NGS technologies, the resulting data and its applications as well as tool development. My research focuses on normalization methods and techniques used for differential gene expression and differential ChIP-seq.”


Gabriele Manhart
Technician (and artist)
“Eager to acquire experience in state of the art techniques and gain a profound background in cancer research, specifically acute myeloid leukaemia, I am participating in various projects and help wherever needed.”

Martin Piontek
MSc student
“I am investigating the role of ABC transporters in different AML cell lines in combination with newly established targeted therapies.”


Torben Redmer
PostDoc
“The focus of our research is the identification of mechanisms and drivers of melanoma metastasis, particularly metastasis to the brain, applying NGS, methylome analyses of patient-derived melanoma brain metastases and cellular model systems as well as confocal imaging of tumors and in vivo (mouse model) and semi-in vivo (organotypic brain-slice culture) approaches.”


Alumni
- Johannes Schmoellerl, PhD student (2014-2020)
- Theresa Humer, Master student (2019-2020)
- Luisa Schmidt, PhD student (2014-2019)
- Stefan Terlecki-Zaniewicz, PhD student (2016-2019)
- Fabio Liberante, PostDoc (2016-2019)
- Lisa Scheiblecker, Master student (2017-2018)
- Konstantina Chatziathanasiou, Technician (2017-2018)
- Nathalie Kuchynka, Bachelor student (2018)
- Anna Skucha, PhD student (2012-2018)
- Anna Katschnig, Technician (2017-2018)
- Frank Ruge, Master Student (2017)
- Christa Van der Veen, Master student (2016)
- Stephanie Kreimel, Bachelor student (2015)
Visiting researchers / Interns
- Ezgi Aslan
- Helene Breid
- Anna Falkner
- Daniel Freund
- Erna Islamagić
- Edwin Rzepa
- Claudio Schmidt
- Maximilian Sexl
- Giacomo Volpe
- Tamina Weiss
